Repligen Corp. (RGEN) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Repligen’s revenue went from $105M in fiscal 2016 to $738M in fiscal 2025, growth of about 24.3% a year.
Net income in fiscal 2025 was $49M, a net margin of 6.6%; the best year in this period was 2022 with $186M.
Over the twelve months to September 30, 2026, revenue was $806M and net income -$12M.
Free cash flow was $94M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 66% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $806M | $738M | $634M | $632M | $802M | $671M | $366M | $270M | $194M | $141M | $105M |
| Gross profit | $431M | $386M | $275M | $278M | $456M | $391M | $210M | $151M | $108M | $74M | $57M |
| Operating income | $18M | $55M | -$35M | $48M | $225M | $167M | $70M | $36M | $26M | $14M | $16M |
| Net income | -$12M | $49M | -$26M | $36M | $186M | $128M | $60M | $21M | $17M | $28M | $12M |
| EPS (diluted) | $-0.21 | $0.86 | $-0.46 | $0.63 | $3.24 | $2.24 | $1.11 | $440.00 | $370.00 | $720.00 | $0.34 |
| R&D | $57M | $54M | $43M | $43M | $44M | $34M | $20M | $19M | $16M | $9M | $7M |
| Revenue growth | — | +16.4% | +0.3% | −21.1% | +19.5% | +83.1% | +35.5% | +39.3% | +37.4% | +35.1% | +25.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $130M | $117M | $175M | $114M | $172M | $119M | $63M | $67M | $33M | $17M | $8M |
| Capital spending | -$23M | -$24M | -$26M | -$36M | -$85M | -$67M | -$22M | -$19M | -$11M | -$5M | -$4M |
| Free cash flow | $107M | $94M | $150M | $78M | $87M | $52M | $40M | $49M | $22M | $12M | $3M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $0 | $0 | $14M | $0 | $0 | — | — | — | — | — |
| Stock-based pay | $34M | $33M | $48M | $26M | $27M | $28M | $17M | $13M | $10M | $7M | $5M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $768M | $757M | $751M | $624M | $604M | $717M | $528M | $194M | $174M | $122M |
| Debt | — | $690M | $686M | $712M | $423M | $366M | $275M | $31M | $103M | — | — |
| Equity | — | $2.1B | $2.0B | $2.0B | $1.9B | $1.8B | $1.5B | $1.1B | $616M | $592M | $169M |
| Total assets | — | $2.9B | $2.8B | $2.8B | $2.5B | $2.4B | $1.9B | $1.4B | $775M | $744M | $289M |
| Shares (diluted) | 57M | 0M | 0M | 0M | 0M | 0M | 0M | 0M | 0M | 0M | 0M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 53.5% | 52.3% | 43.3% | 44.0% | 56.9% | 58.4% | 57.2% | 55.9% | 55.4% | 52.5% | 54.9% |
| Operating margin | 2.3% | 7.5% | -5.5% | 7.5% | 28.0% | 24.9% | 19.1% | 13.4% | 13.4% | 9.9% | 15.3% |
| Net margin | -1.5% | 6.6% | -4.0% | 5.6% | 23.2% | 19.1% | 16.4% | 7.9% | 8.6% | 20.1% | 11.2% |
| FCF margin | 13.2% | 12.7% | 23.6% | 12.3% | 10.9% | 7.7% | 11.0% | 18.0% | 11.4% | 8.5% | 3.1% |
| ROIC | — | 1.6% | -1.2% | 1.1% | 8.2% | 6.6% | 3.1% | 2.7% | 2.8% | 1.9% | 9.5% |
| ROE | — | 2.3% | -1.3% | 1.8% | 9.7% | 7.3% | 3.9% | 2.0% | 2.7% | 4.8% | 6.9% |
Frequently asked questions
What is Repligen’s annual revenue?
$738M in fiscal 2025 and $806M over the twelve months to September 30, 2026.
How much profit does Repligen make?
Net income was $49M in fiscal 2025 (net margin 6.6%).
Is Repligen’s revenue growing?
Yes: revenue rose 16.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.